Balyasny Asset Management’s Intelligent Medicine Acquisition Corp. Warrant IQMDW Stock Holding History

Balyasny Asset Management’s Portfolio IQMDW Stock Details IQMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-100,000	Closed	-$4.6K	–	3187
2023 Q1	$4.6K	Hold	100,000	–	–	﹤0.01%	2552
2022 Q4	$1.05K	Hold	100,000	–	–	﹤0.01%	2699
2022 Q3	$10K	Hold	100,000	–	–	﹤0.01%	2652
2022 Q2	$13K	Hold	100,000	–	–	﹤0.01%	2552
2022 Q1	$28K	Hold	100,000	–	–	﹤0.01%	2322
2021 Q4	$49K	Buy	+100,000	New	+$50.2K	﹤0.01%	2077

Balyasny Asset Management's IQMDW Position: Q2 2023 in Review

Balyasny Asset Management sold out of Intelligent Medicine Acquisition Corp. Warrant (IQMDW) in Q2 2023, closing a stake of 100,000 shares — an estimated $4.6K sold.

Balyasny Asset Management first reported a position in IQMDW in Q4 2021 and held it in 6 quarters. The position peaked at $49K in Q4 2021. 0 funds tracked by Wall St. Rank hold IQMDW as of Q2 2023.

Balyasny Asset Management reported no remaining Intelligent Medicine Acquisition Corp. Warrant position as of Q2 2023 after selling out during the quarter.
Balyasny Asset Management sold 100,000 Intelligent Medicine Acquisition Corp. Warrant shares in Q2 2023, an estimated $4.6K.
Balyasny Asset Management first reported a position in Intelligent Medicine Acquisition Corp. Warrant in Q4 2021 and held it in 6 quarters.
Balyasny Asset Management's Intelligent Medicine Acquisition Corp. Warrant position peaked at $49K in Q4 2021.
0 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Warrant as of Q2 2023.

Based on Balyasny Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.